Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
PTGX holding history
Protagonist Therapeutics, Inc in every 13F filed by Johnson & Johnson, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,449,183
- Value
- $300.2M
- % of portfolio
- 37.6%
- Quarters held
- 20
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,449,183 | $300.2M | 37.6% | 00.0% | Unchanged | Holders |
| Q1 2026 | 2,449,183 | $258.1M | 39.6% | 00.0% | Unchanged | Holders |
| Q4 2025 | 2,449,183 | $213.9M | 38.5% | 00.0% | Unchanged | Holders |
| Q3 2025 | 2,449,183 | $162.7M | 32.3% | 00.0% | Unchanged | Holders |
| Q2 2025 | 2,449,183 | $136.4M | 40.8% | 00.0% | Unchanged | Holders |
| Q1 2025 | 2,449,183 | $118.4M | 34.6% | 00.0% | Unchanged | Holders |
| Q4 2024 | 2,449,183 | $94.5M | 24.5% | 00.0% | Unchanged | Holders |
| Q3 2024 | 2,449,183 | $110.2M | 25.8% | 00.0% | Unchanged | Holders |
| Q2 2024 | 2,449,183 | $84.9M | 21.2% | 00.0% | Unchanged | Holders |
| Q1 2024 | 2,449,183 | $70.9M | 1.6% | 00.0% | Unchanged | Holders |
| Q4 2023 | 2,449,183 | $56.2M | 1.3% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2,449,183 | $40.9M | 15.0% | 00.0% | Unchanged | Holders |
| Q2 2023 | 2,449,183 | $67.6M | 21.0% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,449,183 | $56.3M | 18.3% | 00.0% | Unchanged | Holders |
| Q4 2022 | 2,449,183 | $26.7M | 7.8% | 00.0% | Unchanged | Holders |
| Q3 2022 | 2,449,183 | $20.6M | 6.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 2,449,183 | $19.4M | 4.9% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,449,183 | $58.0M | 11.0% | 00.0% | Unchanged | Holders |
| Q4 2021 | 2,449,183 | $83.8M | 9.5% | 00.0% | Unchanged | Holders |
| Q3 2021 | 2,449,183 | $43.4M | 3.8% | – | No prior filing | Holders |